Private Capital Management Discloses Passive Stake in Harrow, Inc.

Ticker: HROW · Form: SC 13G · Filed: Jan 9, 2024 · CIK: 1360214

Harrow, INC. SC 13G Filing Summary
FieldDetail
CompanyHarrow, INC. (HROW)
Form TypeSC 13G
Filed DateJan 9, 2024
Risk Levellow
Pages3
Reading Time4 min
Sentimentbullish

Complexity: simple

Sentiment: bullish

Topics: institutional-ownership, passive-investment, SC-13G

TL;DR

**Big money just bought into Harrow, Inc. passively.**

AI Summary

Private Capital Management, LLC, a Delaware-based investment firm, has filed an SC 13G indicating its ownership of Harrow, Inc. common stock as of December 31, 2023. This filing, made under Rule 13d-1(b), signifies that Private Capital Management holds a significant, but passive, stake in Harrow, Inc. (formerly Harrow Health, Inc.), a pharmaceutical preparations company. For investors, this matters because it signals a notable institutional investor sees value in Harrow, Inc., potentially lending credibility to the stock, though the exact percentage of ownership is not detailed in the provided excerpt.

Why It Matters

This filing shows a large institutional investor, Private Capital Management, LLC, has taken a significant, passive position in Harrow, Inc., which can be seen as a vote of confidence in the company's future.

Risk Assessment

Risk Level: low — This filing indicates a passive investment, suggesting no immediate intent to influence company management, which typically poses low risk to existing shareholders.

Analyst Insight

A smart investor would view this as a positive signal, indicating institutional confidence in Harrow, Inc., and might consider further research into the company's fundamentals and recent performance.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What type of filing is this and what does it generally indicate?

This is an SC 13G filing, specifically under Rule 13d-1(b). This type of filing indicates that the reporting person, Private Capital Management, LLC, holds a significant, but passive, ownership stake (typically over 5%) in the issuer, Harrow, Inc., and does not intend to influence or change control of the company.

Who is the reporting person in this filing?

The reporting person is Private Capital Management, LLC, identified with IRS Identification No. 46-3167283 and CIK 0001588456. Their business address is 8889 Pelican Bay Boulevard, Suite 500, Naples, FL 34108.

What company's stock is the subject of this filing?

The subject company is Harrow, Inc., a pharmaceutical preparations company (SIC 2834), with CIK 0001360214. Its common stock has a CUSIP number of 415858109.

When was the event that triggered this filing?

The date of the event which required the filing of this statement was December 31, 2023.

What was Harrow, Inc.'s previous name according to the filing?

According to the filing, Harrow, Inc. was formerly known as Harrow Health, Inc. (name changed on 20181228), Imprimis Pharmaceuticals, Inc. (name changed on 20120301), and TRANSDEL PHARMACEUTICALS INC (name changed on 20070912).

Filing Stats: 980 words · 4 min read · ~3 pages · Grade level 9.2 · Accepted 2024-01-09 10:16:35

Filing Documents

(a)

Item 1(a). Name of Issuer: Harrow, Inc.

(b)

Item 1(b). Address of Issuer’s Principal Executive Offices: 102 Woodmont Blvd., Suite 610, Nashville, TN 37205

(a)

Item 2(a). Name of Person Filing: Private Capital Management, LLC

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence: 8889 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108

(c)

Item 2(c). Citizenship: USA

(d)

Item 2(d). Title of Class of Securities: Common Stock

(e)

Item 2(e). CUSIP Number: 415858109 Page 3 of 6 pages Item 3. If this Statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) ¨ Broker or dealer registered under Section 15 of the Act; (b) ¨ Bank as defined in Section 3(a)(6) of the Act; (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act; (d) x Investment company registered under Section 8 of the Investment Company Act of 1940; (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E) ; (f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F) ; (g) ¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G) ; (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; (j) ¨ A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J) ; (k) ¨ Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K) . If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned**: 3,630,496 (b) Percent of Class: 10.34% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 2,083,781 (ii) shared power to vote or to direct the vote*: 1,546,715 (iii) sole power to dispose or to direct the disposition of: 2,083,781 (iv) shared power to dispose or to direct the disposition of: 1,546,715 Page 4 of 6 pages Item 5. If this statement is being f

View Full Filing

View this SC 13G filing on SEC EDGAR

View on Read The Filing